All In Biotech

Drug Trial Radar · NCT01359020

Ibuprofen, Acetaminophen and Dipyrone to Fever Control in Children

Randomized, Open Label, Comparative, Parallel, Multicenter Trial to Determinate the Efficacy Anf Tolerability of Ibuprofen, Acetaminophen and Dipyrone Drops to Fever Control in Children

Last checked: Nov 19, 2026Latest source record: May 24, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 396 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

396

Actual

Start

Jan 2007

Primary completion

Mar 2008

Study completion Mar 2008

Sponsor

Sponsor type
Industry
First posted
May 24, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 6 months, up to 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study was to compare the efficacy and tolerability of acetaminophen, dipyrone and ibuprofen to fever control in children. For the efficacy asses were compared: * the time to start the action; * the action duration; * the difference between the basal temperature and the lower temperature in the study period. For the tolerability asses all adverse events were recorded, as well as your intensity and the relation to the treatment.

Conditions

  • Fever

Interventions

  • ibuprofen, dipyrone, acetaminophenDrug

    The dosage for the three drugs was the same: 10 milligrams per kilo, oral administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Antipyretic efficacyTime frame: Temperature was verified 15, 30, 45 and 60 minutes, 2, 3, 4, 5, 6, 7 and 8 hours after the administration of the drug.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Instituto de Medicina Integral Professor Fernando Figueira

    Recife, Pernambuco, Brazil

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.